Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Rating) saw unusually-high trading volume on Thursday . Approximately 200 shares traded hands during trading, an increase of 2,757% from the previous session's volume of 7 shares.The stock last traded at $467.95 and had previously closed at $467.95.
Analyst Ratings Changes
Separately, TheStreet raised shares of Bio-Rad Laboratories from a "d+" rating to a "c-" rating in a report on Monday, March 27th.
Get Bio-Rad Laboratories alerts:Bio-Rad Laboratories Stock Performance
The company has a market capitalization of $13.85 billion, a PE ratio of -3.85 and a beta of 0.66. The business's 50-day moving average is $443.89 and its 200-day moving average is $414.16. The company has a debt-to-equity ratio of 0.12, a quick ratio of 4.29 and a current ratio of 5.55.
Bio-Rad Laboratories (NYSE:BIO.B – Get Rating) last issued its earnings results on Thursday, February 16th. The company reported $3.31 earnings per share (EPS) for the quarter. The business had revenue of $730.29 million during the quarter. Bio-Rad Laboratories had a negative net margin of 129.66% and a positive return on equity of 4.59%.
Bio-Rad Laboratories Company Profile
(Get Rating)
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Articles
- Get a free copy of the StockNews.com research report on Bio-Rad Laboratories (BIO.B)
- How to Invest in Central Bank Digital Currency
- Kellogg Company Looks GRRR-eat! At These Levels
- PacWest, First Horizon Shares Plummet On Continued Bank Worries
- Yum! Brands Pulls Back To More Appetizing Levels
- Is it Time for Qualcomm to Start Playing Catch-up?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.